In short: GLP-1 receptor agonists – known as “weight-loss injections” such as semaglutide or the newer tirzepatide – are a milestone in the treatment of obesity and type 2 diabetes. For men, they are doubly interesting: obesity is one of the most common causes of low testosterone levels. Losing weight often also improves hormonal balance. In this article, we explain what these active ingredients can do – and what they mean specifically for men’s health.
Few medical topics are discussed as much today as the new weight-loss medications. Ozempic, Wegovy, Mounjaro – the brand names are on everyone’s lips. Behind them is a class of active ingredients that was originally developed to treat diabetes and has proven highly effective for weight loss: GLP-1 receptor agonists.
For us at Adon, one aspect is particularly relevant, which often gets lost in the public debate: the connection between body weight, metabolism, and the male hormonal balance.
A note beforehand: This article is for informational purposes and does not replace medical advice. These medications are prescription-only and should be taken under medical supervision.
What are GLP-1 receptor agonists?
GLP-1 stands for “glucagon-like peptide 1” – an endogenous intestinal hormone that is released after eating. It causes more insulin to be released, lowers blood sugar, and creates a feeling of satiety. It also slows down gastric emptying, so you stay full longer.
GLP-1 receptor agonists are active ingredients that mimic this hormone. They bind to the same receptors and enhance the effect. The result: less hunger, earlier satiety, fewer calories consumed – and therefore weight loss.
The most important representatives are:
- Semaglutide – the first generation with a very strong effect on weight (known as Ozempic for diabetes treatment and Wegovy for weight reduction).
- Tirzepatide – a newer “second generation” that additionally acts on the receptor of the hormone GIP (dual mechanism of action, known as Mounjaro). In studies, it led to even greater weight loss.
How effective are they?
The data is impressive. In the large STEP-1 study, adults with obesity who received weekly semaglutide lost an average of around 15% of their body weight – significantly more than with lifestyle changes alone (Wilding et al., 2021). Combined with intensive behavioral therapy, the effects were similarly strong (Wadden et al., 2021).
Tirzepatide went even further in the SURMOUNT-1 study: Here, participants in the highest dose achieved an average weight loss of around 21% (Jastreboff et al., 2022).
And it’s not just about the number on the scale: In the SELECT study, semaglutide reduced the risk of major cardiovascular events in people with overweight or obesity without diabetes (Lincoff et al., 2023). This underscores that these medications affect the metabolism as a whole.
Important to know: The effect only lasts as long as the medication is taken. After discontinuation, participants regained most of the weight (Wilding et al., 2022). The treatment should therefore be understood more as long-term therapy – not as a short-term course.
The connection to men’s health: Weight and testosterone
This is where it becomes particularly exciting for men. Overweight – especially belly fat – is closely linked to a low testosterone level. There are several reasons for this:
- In fatty tissue, the enzyme aromatase converts testosterone into estrogen. The more belly fat, the stronger this effect.
- Overweight promotes insulin resistance and metabolic syndrome, which further suppress hormone production.
- A vicious cycle is created: Low testosterone promotes fat accumulation and muscle loss – and more fat further lowers testosterone.
Medical professionals refer to this as “functional hypogonadism” – a testosterone deficiency that is caused not by a testicular defect, but by metabolism. It is common in men with obesity and type 2 diabetes (Grossmann et al., 2019).
The good news: This connection also works the other way around. Weight loss can measurably raise testosterone levels. This is exactly where GLP-1 receptor agonists come into play. A systematic review found evidence that weight loss achieved through GLP-1 active ingredients can improve testicular function and testosterone levels in men (Salvio et al., 2025). A smaller study also showed an improvement in sperm quality in men with obesity and functional hypogonadism (Gregorič et al., 2024).
There are also cautiously optimistic signals for sexual function: Because GLP-1 active ingredients improve weight, blood sugar, and vascular health, they could indirectly have a positive effect on erectile function – but the data here is not yet conclusive (Kounatidis et al., 2025).
Side effects and limitations
GLP-1 receptor agonists are well studied, but they are not free of side effects. The most common are gastrointestinal issues:
- Nausea (especially at the beginning)
- Diarrhea or constipation
- Feeling full and burping
These symptoms usually subside as the body gets used to the gradually increased dose. More serious side effects are rarer. Another important point: With rapid weight loss, muscle mass is lost along with fat. This is why it makes sense for men to accompany the treatment with strength training and sufficient protein to protect their muscle mass.
No substitute for determining the underlying cause
As effective as these medications are – they do not replace a thorough investigation into why someone is gaining weight or has low testosterone levels. Sometimes, lack of motivation, weight gain, and loss of libido are actually caused by a hormonal problem that should be treated independently. How you can regulate your hormonal balance and what role medications play in this can be found in the article Testosterone under therapy.
🎧 For listening: In our podcast Men’s Health, Alexander Friedrich explains weight-loss injections from the perspective of men’s health in the episode Ozempic Weight-Loss Injection – Parallels to TRT. Correspondingly, Prof. Dr. Farid Saad talks about the other side of this connection in How Testosterone Changes Your Metabolism.
Conclusion
GLP-1 receptor agonists such as semaglutide and tirzepatide are a real breakthrough in the treatment of obesity – with proven benefits for weight, metabolism, and cardiovascular health. For men, they are additionally interesting because weight loss can significantly improve testosterone deficiency caused by obesity. But they are not a miracle cure: The effect only lasts as long as the medication is taken, maintaining muscle mass and determining the underlying cause remain important, and their use should be left to medical professionals. They are most effective as part of a comprehensive approach combining diet, exercise, and – where necessary – targeted hormonal treatment.
